Fortis Healthcare Limited

INR 1

althcare announces Q4 FY23 and FY23 Audited Financial Results Board recommends maiden dividend of INR 1 per share (10% of Face Value) Hospital Business Q4FY23 revenue up 29.7% to INR 1,350 Crs, Margins

10%

s Q4 FY23 and FY23 Audited Financial Results Board recommends maiden dividend of INR 1 per share (10% of Face Value) Hospital Business Q4FY23 revenue up 29.7% to INR 1,350 Crs, Margins expand to 17.

29.7%

mmends maiden dividend of INR 1 per share (10% of Face Value) Hospital Business Q4FY23 revenue up 29.7% to INR 1,350 Crs, Margins expand to 17.0% from 13.8% in Q4FY22 Hospital Business FY23 revenue up

INR 1,350

iden dividend of INR 1 per share (10% of Face Value) Hospital Business Q4FY23 revenue up 29.7% to INR 1,350 Crs, Margins expand to 17.0% from 13.8% in Q4FY22 Hospital Business FY23 revenue up 19.8% to INR

rs,

nd of INR 1 per share (10% of Face Value) Hospital Business Q4FY23 revenue up 29.7% to INR 1,350 Crs, Margins expand to 17.0% from 13.8% in Q4FY22 Hospital Business FY23 revenue up 19.8% to INR 5,107

17.0%

10% of Face Value) Hospital Business Q4FY23 revenue up 29.7% to INR 1,350 Crs, Margins expand to 17.0% from 13.8% in Q4FY22 Hospital Business FY23 revenue up 19.8% to INR 5,107 Crs, Margins expand to

13.8%

Value) Hospital Business Q4FY23 revenue up 29.7% to INR 1,350 Crs, Margins expand to 17.0% from 13.8% in Q4FY22 Hospital Business FY23 revenue up 19.8% to INR 5,107 Crs, Margins expand to 18.1% from

19.8%

to INR 1,350 Crs, Margins expand to 17.0% from 13.8% in Q4FY22 Hospital Business FY23 revenue up 19.8% to INR 5,107 Crs, Margins expand to 18.1% from 15.8% in FY22 Company’s net debt to EBITDA at 0.2

INR 5,107

350 Crs, Margins expand to 17.0% from 13.8% in Q4FY22 Hospital Business FY23 revenue up 19.8% to INR 5,107 Crs, Margins expand to 18.1% from 15.8% in FY22 Company’s net debt to EBITDA at 0.29x versus 0.60

18.1%

from 13.8% in Q4FY22 Hospital Business FY23 revenue up 19.8% to INR 5,107 Crs, Margins expand to 18.1% from 15.8% in FY22 Company’s net debt to EBITDA at 0.29x versus 0.60x in FY22 FY23 vs FY22 ➢

15.8%

in Q4FY22 Hospital Business FY23 revenue up 19.8% to INR 5,107 Crs, Margins expand to 18.1% from 15.8% in FY22 Company’s net debt to EBITDA at 0.29x versus 0.60x in FY22 FY23 vs FY22 ➢ Consolidate

0.29x

.8% to INR 5,107 Crs, Margins expand to 18.1% from 15.8% in FY22 Company’s net debt to EBITDA at 0.29x versus 0.60x in FY22 FY23 vs FY22 ➢ Consolidated Revenues at INR 6,298 Crs, up 10.1% ➢ EBITDA

“By attending or assessing this presentation you acknowledge that you will be solely responsible for your own assessment of the market and the market position of the Company and that you will conduct your own analysis and be solely responsible for forming your own view of the potential future performance of the business of the Company.”

Cash

2

For further details please contact

1

For further details please contact

Anurag Kalra / Gaurav Chugh Investor Relations +91-9810109253 / 9958588900 Fortis Healthcare Limited Ajey Maharaj Corporate Communication +91-9871798573 Fortis Healthcare Limited 6/6 FORTIS HEALTHCARE LIMITED EARNINGS PRESENTATION – Q4 FY23 & FY23 May 23, 2023 DISCLAIMER This presentation may not be copied, published, distributed or transmitted. The presentation has been prepared solely by the company. Any reference in this presentation to “Fortis Healthcare Limited” shall mean, collectively, the Company and its subsidiaries. This presentation has been prepared for informational purposes only. This presentation does not constitute a prospectus, offering circular or offering memorandum and is not an offer or invitation to buy or sell any securities, nor shall part, or all, of this presentation form the basis of, or be relied on in connection with, any contract or investment decision in relation to any securities. Furthermore, this presentation is not and should not be construed as an of

Cash

Domestic, 36.4% Pvt Corps, 0.9% Govt & PSUs, 9.7% CGHS, 3.0% Pvt Corps, 1.0% International , 4.8% ECHS, 4.5% Govt & PSUs, 9.7% CGHS, 3.4% ECHS, 6.1% International , 7.9% HOSPITAL BUSINESS PERFORMANCE – Q4FY23 & FY23 All the key healthcare facilities continue to witness an upward momentum in revenues Revenue Q4FY22 Q4FY23 201 145 153 111 116 82 115 95 114 85 112 85 105 82 72 53 43 48 41 47 FMRI Mohali Noida BG Road Shalimar Bagh FEHI Mulund Anandpur Jaipur Faridabad Revenue FY22 FY23 754 571 575 457 462 381 430 350 421 323 407 339 395 353 262 233 211 179 182 182 250 200 150 100 50 - 800 600 400 200 - FMRI Mohali BG Road Shalimar Bagh Noida FEHI Mulund Anandpur Jaipur Faridabad All figures in INR Crs. HOSPITAL BUSINESS PERFORMANCE – FY23 Seven of the top 10 hospitals witnessing occupancy in excess of 70% ARPOB (INR'000 per day) FY22 FY23 96.0 79.5 67.4 61.3 74.7 66.6 66.3 57.2 53.8 48.4 55.1 51.4 53.2 52.7 40.3 42.4 33.4 29.7 32.5 33.8 FMRI Mohali BG Road Shalimar Bagh Noida FEHI Mulund